20882 ⎘
Medicinal preparations containing peptides Enzyme inhibitors
Lisinopril formulations
#302Selective caspase inhibitors and uses thereof
#303Method for inhibiting ADAM proteases with cyclic peptides
#304Combination
#305Compositions and methods of treating root avulsion injury
#306ARTIFICIAL SKIN
#307Compositions targeting the interaction domain between p27KiP1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity
#308JNK inhibitor molecules for treatment of various diseases
#309Agents and methods of treatment
#310Compositions and methods for treating heart disease and/or injury
#311Compositions and methods for delivery of kinase inhibiting peptides
#312Treatment of autoimmune disorders and infections using antagonists of SGK1 activity
#313Therapeutically active compositions and their methods of use
#314SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF
#315CARDIOLIPIN-TARGETED PEPTIDES INHIBIT BETA-AMYLOID OLIGOMER TOXICITY
#316Methods and compositions for preserving retinal ganglion cells
#317Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
#318Pharmaceutical composition for preventing or treating cancer, containing proteasome inhibitor and loperamide as active ingredients
#319Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#320Composition and method for therapeutic agent delivery during pregnancy
#321THIOPHENE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OFUSE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
#322Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
#323HCV protease inhibitors and uses thereof
#324Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
#325CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#326Pan-antiviral peptides for protein kinase inhibition
#327Compositions and methods for the treatment of cancer
#328Cyclic peptides as ADAM protease inhibitors
#329Compositions and methods for efficacious and safe delivery of siRNA using specific chitosan-based nanocomplexes
#330LIPOPEPTIDE INHIBITORS OF RAS ONCOPROTEINS
#331Methods for treating spinal cord injury
#332Method of Diagnosis or Prognosis of a Neoplasm Comprising Determining the Level of Expression of a Protein in Stromal Cells Adjacent to the Neoplasm
#333THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE
#334Lung injury repair compositions and methods
#335Inhibitors of NOX1
#336USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY EYE DISEASES
#337Conjugate comprising P21 protein for the treatment of cancer
#338Hepatitis C virus inhibitors
#339Polyplexes
#340Composition including the HIP/PAP protein or one of the derivatives thereof for treating insulin resistance
#341Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
#342Treatment of myocardial infarction by inhibiting the action of mAKAPβ
#343Methods and compositions for inhibiting glyoxalase 1 (GLO1)
#344Bruton's tyrosine kinase inhibitor combinations and uses thereof
#345SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF
#346Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#347Methods and Compositions for the Prevention and Treatment of Parasitic Disease
#348Methods and compositions for inducing apoptosis by stimulating ER stress
#349Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#350High affinity digoxigenin binding proteins
#351Products and methods using soy peptides to lower total and LDL cholesterol levels
#352Extracellular matrix encasement structures and methods
#353Extracellular matrix encasement structures and methods
#354Extracellular matrix encasement structures and methods
#355Extracellular matrix encasement structures and methods
#356Combination of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent
#357Combinations of a caspase inhibitor and an antiviral agent
#358Extracellular matrix encasement structures and methods
#359Extracellular matrix (ECM) structures for tissue regeneration
#360HMGB1 variants and uses thereof
#361USE OF CASPASE 3 ACTIVITY AND ITS INHIBITORS
#362PHARMACEUTICAL COMPOSITION FOR TREATING HYPERPROLIFERATIVE DISEASES
#363Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban
#364NOVEL CORE-SHELL NANOPARTICLES FOR ORAL DRUG DELIVERY
#365EGFR antagonist for the treatment of heart disease
#366Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses
#367Peptide agents for cancer therapy
#368Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
#369Extracellular matrix encasement structures and methods
#370Method of treating motor neuron disease with an antibody that agonizes MuSK
#371THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
#372Macrocyclic compounds for suppressing replication of hepatitis C virus
#373Compositions and methods for delivery of kinase inhibiting peptides
#374Selective caspase inhibitors and uses thereof
#375Macrocyclic compounds useful as inhibitors of histone deacetylases
#376METHOD FOR REDUCING BLOOD PRESSURE USING INHIBITORS OF PLASMA KALLIKREIN
#377Extracellular matrix encasement structures and methods
#378Kinase inhibitors and uses thereof
#379Extracellular matrix (ECM) structures for tissue regeneration
#380MODULATION OF AXON DEGENERATION
#381Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
#382METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#383Methods for treating obesity
#384ICE INHIBITING COMPOUNDS AND USES THEREOF
#385HCV NS3 protease inhibitors
#386METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS BY STIMULATING ER STRESS
#387Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)
#388Increasing parkin activity by administering a deubiquitinating enzyme inhibitor
#389Taste masked pharmaceutical composition
#390Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
#391Scaffold-kinase interaction blockades and uses thereof in treating cancer
#392METHODS AND COMPOSITIONS FOR TREATMENT OF LESIONED SITES OF BODY VESSELS
#393Caspofungin or salts thereof with high purity, as well as preparation method and use thereof
#394TREATMENT OF AUTOIMMUNE DISORDERS AND INFECTIONS USING ANTAGONISTS OF SGK1 ACTIVITY
#395MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS
#396ALPHA SYNUCLEIN TOXICITY
#397Compositions and methods for the treatment of cancer
#398Products and methods using soy peptides to lower total and LDL cholesterol levels
#399GRANZYME B INHIBITOR COMPOSITIONS, METHODS AND USES FOR PROMOTING WOUND HEALING
#400Pharmaceutical composition for treating hyperproliferative diseases
#401DRUG SUBSTANCES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREPARING THE SAME
#402Compounds and methods for preventing or treating a viral infection
#403Methods and pharmaceutical compositions for inhibiting influenza viruses replication
#404Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors
#405METHODS AND COMPOSITIONS FOR PRESERVING RETINAL GANGLION CELLS
#406Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
#407Ice-cleaved alpha-synuclein as a biomarker
#408Delivering polypeptides to phagocytes
#409COMBINATION
#410TARGETING SENESCENT CELLS AND CANCER CELLS BY INTERFERENCE WITH JNK AND/OR FOXO4
#411Regulators of MMP-9 and uses thereof
#412COMBINATION THERAPY FOR CHEMORESISTANT CANCERS
#413METHODS OF TREATING AND PREVENTING THROMBOTIC DISEASES USING ASK1 INHIBITORS
#414SIR2 regulation
#415Methods and compositions for the inhibition of fructokinase
#416Macrocyclic serine protease inhibitors
#417Macrocyclic compounds useful as inhibitors of histone deacetylases
#418HIGH POTENCY FORMULATIONS OF VX-950
#419Kinase inhibitors and uses thereof
#420Inhibitors of Serine Proteases
#421TREATMENT OF PITUITARY CORTICOTROPH TUMORS USING R-ROSCOVITINE
#422COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#423Fructose 1, 6-biphosphatases as new targets for diagnosing and treating breast cancer brain metastasis
#424METHODS AND COMPOSITIONS FOR PRESERVING PHOTORECEPTOR AND RETINAL PIGMENT EPITHELIAL CELLS
#425Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus
#426Transglutaminase inhibitors and methods of use thereof
#427PROTEIN HYDROLYSATE ENRICHED IN PEPTIDES INHIBITING DPP-IV AND THEIR USE
#428INHIBITORS FOR TREATING AND PREVENTING HEART FAILURE IN FELINES
#429Extracellular matrix encasement structures and methods
#430Artificial skin
#431Hepatitis C virus inhibitors
#432Modulation of Axon Degeneration
#433Thiophene analogues for the treatment or prevention of flavivirus infections
#434COMBINATION
#435Methods for Treating Autoimmune Disorders, and Reagents Related Thereto
#436CYSTATIN C AS AN ANTAGONIST OF TGF-BETA AND METHODS RELATED THERETO
#437Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm
#438Method of regulating glucose metabolism, and reagents related thereto
#439COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRABBE AND OTHER NEURODEGENERATIVE DISEASES
#440LYSINE-SPECIFIC DEMETHYLASE 1(LSD1) IS A BIOMARKER FOR BREAST CANCER
#441USE OF PKC ISOZYMES FOR DIAGNOSIS AND TREATMENT OF NEUROBLASTOMA
#442METHOD FOR TREATING OR AMELIORATING MUCOCUTANEOUS OR OCULAR TOXICITIES
#443Thiophene analogues for the treatment or prevention of flavivirus infections
#444COMPOSITIONS AND METHODS FOR TREATMENT OF BODY WEIGHT CONDITIONS
#445Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy
#446Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer
#447Alleviate back pain with lactic acid inhibitors
#448Laminate sheet articles for tissue regeneration
#449ALPHA SYNUCLEIN TOXICITY
#450Methods and compositions for inducing apoptosis by stimulating ER stress
#451METHOD FOR REDUCING BLOOD PRESSURE USING INHIBITORS OF PLASMA KALLIKREIN
#452Hepatitis C virus inhibitors
#453Drug Therapy for Celiac Sprue
#454CARDIAC TREATMENT USING ANTI-FIBROTIC AGENTS
#455Selected inhibitors of protein tyrosine kinase activity
#456Inhibitors of protein tyrosine kinase activity
#457Modulators of pharmacokinetic properties of therapeutics
#458Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors
#459Pan-antiviral peptides for protein kinase inhibition
#460SIR2 regulation
#461Method of regulating glucose metabolism, and reagents related thereto
#462INHIBITORS OF SERINE PROTEASES
#463Selective caspase inhibitors and uses thereof
#464REGULATORS OF MMP-9 AND USES THEROF
#465Conjugate comprising P21 protein for the treatment of cancer
#466Protein kinase C peptides for use in withdrawal
#467Compositions and methods for the treatment of cancer
#468BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM
#469Methods of treatment using a vector encoding p21/
#470COMPOUNDS FOR PREVENTING OR TREATING A VIRAL INFECTION
#471PROTEASE INHIBITION
#472Assay for identifying a modulator of HIF hydroxylase
#473Cystatin C as an antagonist of TGF-β and methods related thereto
#474Macrocyclic serine protease inhibitors
#475Methods and compositions for treatment of lesioned sites of body vessels
#476Use of inhibitors and antisense oligonucleotides of BTK for treating proliferative mastocytosis
#477METHODS FOR USING SOY PEPTIDES TO INHIBIT H3 ACETYLATION, REDUCE EXPRESSION OF HMG-COA REDUCTASE AND INCREASE LDL RECEPTOR AND SP1 EXPRESSION IN A MAMMAL
#478HCV protease inhibitors and uses thereof
#479CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#480Transglutaminase inhibitors and methods of use thereof
#481USE OF GSK-3 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER
#482Treating severe and acute viral infections
#483Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation
#484Modulators of pharmacokinetic properties of therapeutics
#485Hepatitis C virus inhibitors
#486LAMINATE SHEET ARTICLES FOR TISSUE REGENERATION
#487Axon Regeneration with PKC Inhibitors
#488Kinase Inhibitors And Uses Thereof
#489Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy
#490Compositions and methods for treatment of macular degeneration and related conditions
#491INHIBITION OF GLYCOGEN SYNTHASE KINASE 3 BETA IN ARTERIAL REPAIR AND STENT RE-ENDOTHELIALIZATION
#492Cystatin C as an antagonist of TGF-β and methods related thereto
#493Method of regulating glucose metabolism, and reagents related thereto
#494Process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells
#495Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use
#496Methods and compositions for including apoptosis by stimulating ER stress
#497Transglutaminase inhibitors and methods of use thereof
#498Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease
#499Thiophene analogues for the treatment or prevention of flavivirus infections
#500Method of Preparing a Food Ingredient and Food Product Having Angiotensin-I-Converting Enzyme Inhibiting Properties and Products Thus Obtained
#501Conjugate Comprising P21 Protein for the Treatment of Cancer
#502LAMINATE SHEET ARTICLES FOR TISSUE REGENERATION
#503Protein kinase C peptides for use in withdrawal
#504COMPOSITIONS AND METHODS FOR CHARACTERIZING, REGULATING, DIAGNOSING, AND TREATING CANCER
#505Drug Therapy for Celiac Sprue
#506Methods of treatment involving p21/CIP1
#507Method to Enhance the Bone Formation Activity of Bmp by Runx2 Acetylation
#508Method for inhibition of viral infection
#509Isolated Dipeptides with Ace Inhibitor Effect
#510Cyclin-dependent kinase inhibitors as targets for opiod growth factor treatment
#511Novel Use of the Kinases Rsk4 and Pak5
#512Modulators of pharmacokinetic properties of therapeutics
#513Amphiregulin as a Protective Agent in Acute Hepatic Injury
#514DRUG THERAPY FOR CELIAC SPRUE
#515ILK inhibitors for the treatment of renal disease
#516Methods and compositions for prevention or treatment of inflammatory-related diseases and disorders
#517Methods and compositions for treatment of lesioned sites of body vessels
#518Induction of apoptosis by inhibition of sirtuin SIRT1 expression
#519Use of caspase inhibitors as a therapeutic agent against radiation-induced injury
#520Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer
#521Peptide having an ace inhibiting effect
#522Method of detecting effect of controlling synoviolin activity
#523Method of regulating glucose metabolism, and reagents related thereto
#524Milk fractions and milk preparations for treating and/or preventing COX-2 mediated diseases
#525Inhibitors of serine proteases
#526Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
#527Therapeutic compounds
#528Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
#529Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
#530Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation
#531Therapeutic agent for soft tissue sarcoma
#532Caspase inhibitors as anticancer agents
#533Hepatitis C virus inhibitors
#534Modulators
#535Use of an inhibitor of cathepsin-S or -B to treat or prevent chronic obstructive pulmonary disease
#536Compositions and methods for treatment of body weight conditions
#537Transglutaminase inhibitors and methods of use thereof
#538Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
#539Method for inhibition of viral infection
#540Treating severe and acute viral infections
#541Use of an inhibitor of cathepsin-S-or-B to treat or prevent chronic obstructive pulmonary disease
#542Cystatin C as an antagonist of TGF-β and methods related thereto
#543Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
#544Use of immunomodulating agents
#545Methods of enhancing stem cell engraftment
#546Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
#547Method of inhibiting vascular permeability
#548Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
#549Combination therapy comprising a Cox-2 inhibitor and an antineoplastic agent
#550Protein kinase C peptides for use in withdrawal
#551Gastroprotected formulations containing alph-amylase inhibitors
#552Protein kinase C peptides for use in withdrawal
#553JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection
#554Therapeutic compounds
#555Prevention of photic injury by administering a TACE inhibitor
#556Axon regeneration with PKC inhibitors
#557Ilk inhibitors for the treatment of renal disease
#558Therapeutic agent for soft tissue sarcoma
#559Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
#560Compositions and methods for treatment of body weight conditions
#561Methods for treating autoimmune disorders, and reagents related thereto
#562Medicaments comprising inhibitors of the cell volume-regulated human kinase h-sgk
#563Methods of inhibiting neurodegenerative disease
#564Methods of identifying kinases and uses thereof
#565Protease inhibitor:protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria
#566Treatment of HIV-1 infection and AIDS